Parkinsonism--drug treatment: Part I

The purpose of this two-part review is to explain current drug treatment in part I and discuss investigational drug therapy and miscellaneous drugs in the management of parkinsonism in part II. The medical approach to this disease is still based on the imbalance between a deficiency of dopamine and...

Full description

Saved in:

Bibliographic Details
Published in:	Drug intelligence & clinical pharmacy Vol. 21; no. 1 Pt 1; p. 10
Main Authors:	Berg, M J, Ebert, B, Willis, D K, Host, T, Fincham, R W, Schottelius, D D
Format:	Journal Article
Language:	English
Published:	United States 01-01-1987
Subjects:	Antiparkinson Agents - pharmacology Humans Parkinson Disease - drug therapy
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The purpose of this two-part review is to explain current drug treatment in part I and discuss investigational drug therapy and miscellaneous drugs in the management of parkinsonism in part II. The medical approach to this disease is still based on the imbalance between a deficiency of dopamine and a functional increase in acetylcholine. Anticholinergic agents are used to treat the tremors in the early stages of the disease.
ISSN:	0012-6578
DOI:	10.1177/10600280870211P101